Glenmark Pharmaceuticals Inc USAJune 16, 2025

FDA 483 - Glenmark Pharmaceuticals Inc USA - June 16, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Glenmark Pharmaceuticals Inc USA

Record Details

Unable to generate a concise summary as the provided document content is empty and contains no information regarding an FDA 483 inspection. The document only indicates page numbers without any textual content related to a company name, inspection dates, main violations, regulatory framework, or required actions. Please provide the full text of the inspection report to allow for accurate summarization.

Company: Glenmark Pharmaceuticals Inc USA
Inspection Date: June 16, 2025
Product Type: Other
Office: Division of Information Disclosure Policy
People: Sandrea A. Munroe
Damaris V. Hernandez
Homero W. Aguilar
Luis P. Torres

Open in Dashboard

ID · facf78be-e9f5-44d2-ad1f-a2fccd330cdc